Browsing College of Medicine by Subject "BCL2 inhibitors"
Now showing items 1-1 of 1
-
The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review
( MDPI , 2024 , Article Review)Intermittent fasting (IF) has recently gained popularity due to its emerging benefits in reducing weight and improving metabolic health. Concurrently, novel agents (NAs) like venetoclax and Bruton tyrosine kinase inhibitors ...